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Abstract - Chronic pain raises stress conditions such as depression that can lower the cellular immunity. Fluoxetine is an antidepressant
used as an adjuvant in pain management but no one has been linked it with the body immune system. The objectives of this research were to
proof the benefits of fluoxetine in  preventing degradation of macrophage function in chronic pain by measuring the macrophage
phagocytic index , macrophage NO levels and the liver bacterial count in BALB/c mice infected with Listeria Monocytogenes.A Post Test -
Only Control Group Design was conducted using 28 male mice strain BALB /c, age 8-10 weeks. The control group (C), mice got the same
standard feed as the other groups. Chronic pain group (P), mice were injected with 20μL intraplantar CFA on day-1. Pain + fluoxetine
early group (PFE) were treated with P + fluoxetine 5 mg / kg ip day-1, the 4th, the 7th and the 10th, while the Pain + fluoxetine late
group (PFL) were treated with P + fluoxetine 5 mg / kg ip on day 7th and 10th. All mice were injected with 104 live Listeria
monocytogenes iv on day 8th. Termination was performed on day 13th. Differences within groups  were analyzed using  One-way ANOVA
and Kruskall Wallis, whereas the correlation of variables were analyzed using  Pearson's product moment. The experimental results
showed that The macrophage phagocytic index and NO macrophage level (pg/mL) in PFE group(2,24±1,013; 0,24±0,239) was higher
than than P group (1,68±0,920; 0,21±0,263) and there was no different in the macrophage phagocytic index of PFE group compared to C
group (p=0,583; p=0,805). In PFL group (4,32±1,459; 0,54±0,294) the macrophage phagocytic index as well as NO macrophage level
(pg/mL) was higher than P group (1,68±0,920; 0,21±0,263) with p=0,002; p=0,017. P group Bacterial count (log cfu/gram) (2,30±0,849)
was significantly higher than C group(1,15±0,223) (p=0,007), while PFE group bacterial count (1,96±0,653) and PFL group bacterial
count (1,84±0,403) compared to C (1,15± 0,223) was not significantly different (p=0,093; p=0,220). Correlation found between
macrophage phagocytic index and macrophage NO (r=0,515, p=0,005).Macrophage phagocytic index and macrophage NO showed no
correlation with bacterial count (r=-0,051, p=0,798; r=-0,071, p=0,719).It can be concluded that fluoxetine significantly incerases
macrophage phagocytosis index and macrophages NO level in mice with chronic pain,  on the other hand fluoxetine decreases liver
bacterial count . There is a positive correlation between macrophage phagocytosis index and macrophages NO level, while no correlation
observed  among two variables with mice liver bacterial count in chronic pain.
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I. INTRODUCTION
Chronic pain, a condition related to stress and depression,
is the most common psychiatric problem as  reported by the
Survey of Chronic Pain in Europe as well as by  American
Chronic Pain Association.1,2 Study report shows there is a
molecular mechanism that connects depression to stress. For
example, Cortisol elevation caused by stress increases
serotonin uptake both in the stimulated and the unstimulated
nerves, this findings is consistent with the symptoms of
depression.3 Chronic response to stress involves the
Hypothalamic-Pituitary-Adrenal Axis (HPA Axis) result in
huge secretion of glucocorticoid which will be bound to the
immune system receptors and leads to cellular immunity
suppression. Depression correlates with high resistance to
molecules normally work to cut  the inflammation cascade.
Failure index of inflammatory regulation underlines the
morbidity and mortality related to depression.4
Antidepressant used  as  adjuvant therapy in the
management of chronic pain  may alleviate pain but none has
correlated it with body immune system. Studies show that
fluoxetine has been used and brings good efficacy in
releaving  pain and depression. Fluoxetine is a central
selective serotonin reuptake inhibitor. Studies prove that
Fluoxetine as a monotherapy or in combination is beneficial
to  pain management.5 Minimal  side effect  compared to
other anti-depressant particularly tricyclic group, low dose
therapy using fluoxetine and can also be easily increase to
reach the desired analgesic effect. Fluoxetine has been widely
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used in the form of capsules, tablets or solutions. Study by
Federal Aviation Administration (FAA) recommended that
pilots receiving fluoxetine would still be allowed tofly.6
Antipsychotic and antidepressant usage is at the top of  the
central nervous system 2011 drug prescription list in America,
among those drugs Fluoxetine was at the fifth rank in
prescription numbers of 24,5 millions.7 Fluoxetine is also
used  as  pain adjuvant therapy listed in the first national
consensus of diagnostic and management of pain Perdossi
2011.8
This study explained the effect of fluoxetine on
macrophage function in Chronic pain. In chronic pain
conduction,  subsequent stress modifies body immune system
including innate and adaptive immunity. Macrophage holds
important role in the observation of fluoxetine’s effect to
innate and adaptive immunity for its involvement in both
systems. Macrophage function response observed by
inducting individual infection by using Listeria
monocytogenes. Macrophage function response was
measured using macrophage phagocytic index and
macrophage nitric oxide (NO) concentration. Interaction
result of various body immunity was determined by
calculating the bacterial count.
II. MATERIAL AND METHOD
A Post Test - Only Control Group Design.9 was conducted
using 28 male mice strain BALB /c, age 8-10 weeks. The
control group (C), mice got the same standard feed  as the
other groups. 20 µL intraplantar CFA were injected in
Chronic pain group (P) mice  on day-1. Pain + fluoxetine
early group (PFE) mice were treated with P + fluoxetine 5 mg
/ kg ip on  day-1, the 4th, the 7th and the 10th, while the Pain +
fluoxetine late group (PFL) mice were treated with P +
fluoxetine 5 mg / kg ip on day 7th and 10th. All mice were
injected with 104 live Listeria monocytogenes iv on day 8th.
Termination performed on day 13th. the macrophage
phagocytic index, macrophage NO level as well as bacterial
count from BALB/c mice liver were all measured.
Mice liver were obtained aseptically for the bacterial
count in cfu/gram. Measurement were performed by counting
the bacterial colony growth in blood agar+tellurite media after
liver smear incubation for 24 hours. Liver smear were
performed  with grinder and staged dilution using NaCl 0,9%
to be planted in the blood agar+tellurite media. Colony
growth were calculated using colony counter.10
Mice peritoneal macrophage were isolated then incubated
in the temperature of 37oC, with 5% level of CO2 for 2 hours
in  plate 96 wells to measure the macrophage NO level. After
medium change, the macrophage was cultured in 37 °C
incubator, with 5% level of CO2 for 24 hours. Macrophage
NO level measurement were performed using  Griess method
and read by Elisa Microplate Reader 680 XR in 450 nm
wave.11
The macrophage suspension was cultured for macrophage
phagocytic index in 24 well microplates which had been
applied with round coverslips in 5% CO2 incubator  with the
temperature of 37oC for  30 minutes then added on complete
medium and was incubated there for 2 hours. After being
cleansed with Roswell park memorial institute medium
(RPMI), complete mediums added and then was incubated for
24 hours. After being re-cleansed with RPMI, 200 µl/ well
latex suspensions of  2,5 x 107/ml concentration were added
and then incubated in 5% CO2 incubator with the temperature
of 37oC for 60 minutes. Cover slips were dried in room
temperature, fixated with absolute methanol, and then dyed
with Giemsa 20% for 30 minutes. After being cleansed with
aquadest, cover slips were removed from culture well and
dried in room temperature. The amount of latex particle
phagocytized by mice peritoneal macrophage was calculated
by using the light microscope.
The result data was processed and presented in graphics.
Phagocytic index shows normal distribution after normality
test using  Saphiro Wilk test (p>0,05), the bacterial count
variable data was transformed  into  log10 to fulfill the
normality assumption (p>0,05). Afterwards parametric
analysis was performed using  One Way Anova to determine
the difference among 4 treatment groups. The  difference
between every treatment groups were analyzed using
Bonferroni Post Hoc Test. The Post Hoc Test was selected
because the variance fulfills the homogenity assumption
(Levene’s test p>0,05). For  Nitric Oxide variable,
macrophage did not fulfill the normality assumption (p<0,05),
so Kruskall-Wallis test was performed  to observe the
difference between four treatment groups. The  difference
were all futher analyzed by Mann-Whitney posteriority test.
To observe the correlation of each variables  Pearson’s
product moment bivariate correlation test were performed. All
statistical analysis were processed by computer using the
SPSS. Level of Significant in this study is when the variable
analyzed had p <0,05. This study acquired the ethical
clearance from the Health Study Ethical Comission of Undip
medical faculty and Kariadi General hospital.
III. RESULT AND DISCUSSION
The macrophage phagocytic index and NO macrophage level
(pg/mL) in PFE mice (2,24±1,013; 0,24±0,239) was higher than
than in P mice (1,68±0,920; 0,21±0,263). There was no different
in macrophage phagocytic index and NO macrophage level
(pg/mL) in PFE mice compared to C mice (p=0,583; p=0,805)
while in PFL mice the macrophage phagocytic index and NO
macrophage level (4,32±1,459; 0,54±0,294) was higher than in P
mice (1,68±0,920; 0,21±0,263) with p=0,002; p=0,017. P mice
Bacterial count (log cfu/gram) (2,30±0,849) was significantly
higher than C mice (1,15±0,223)  (p=0,007), while bacterial
count for PFE (1,96±0,653) and PFL (1,84±0,403) compared to
C (1,15± 0,223) wasnot different (p=0,093; p=0,220).
Correlation found between macrophage phagocytic index and
macrophage NO (r=0,515, p=0,005). Macrophage phagocytic
index and macrophage NO show no correlation with bacterial
count (r=-0,051, p=0,798; r=-0,071, p=0,719).
Nociceptor sensitization with Complete freund’s adjuvant
(CFA) produces action potential transmitted by A-δ and or C
fiber. Both nerve fibers end in superficial layer of dorsal horn and
continued by gelatinous substance transmission cell towards
thalamus, the important part  for impulse integration in brain.12-14
Chronic pain is a stress condition which causes elimination of
glucocorticoid negative feedback in the Hypothalamic-Pituitary-
Adrenal Axis (HPA Axis). Chronic pain also causes diminished
monoaminergic tone in monoaminergic depletion response
induced by glucocorticoid, this causes inhibitory impulse to
decrease. Aside from that, chronic pain causes downregulation of
glucocorticoid modulation and this scheme leads to depressed
mood.15
Both in animal and human studies, survival mechanism
during chronic stress is not only by increasing corticosteroid
hormon secretion maintained by negative feedback control, but
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also by releasing additional corticosteroid response related to
stressor. Each of adaptive responses involves HPA Axis.16
However, continous ongoing and prolonged stress may interrupt
the HPA axis, oneof which is the disruption of negative feedback
mechanism. Physiologic changes in countering stressor will help
individulas to fight  the stressor. Chronic response to stress
involves the HPA axis and symphatetic-adrenal-medullary axis
(SAM axis) by chronic ongoing production of glucocorticoid and
cathecolamine as final result. Chronic stress may flatten circadian
rhythm of glucocorticoid production and increases ultradian
frequency.17,18 This shows involvement of biological clock in
diseases related to stress. Glucocorticoid is not only resulted from
circadian rhythm of adrenal gland, central and peripheral setting,
but also may influence the circadian rhythm itself and interacts
with other biological clock in circadian rhythm physiologically.19
Chronic pain effects on body immunity using several
mechanisms as demonstrated in previous studies  described
above observed from the low level of  macrophage phacoytic
index (1,68±0,920) and macrophage NO 0,21±0,263 pg/mL in
chronic pain group (P)  (Fig 1). This result also supported by
previous theories and studies that glucocorticoid reseptor
expressed in  various immune cells will bind cortisol alongside
NF- B function and regulates immune cells cytokine production.
Adrenergic receptor binds epinephrine and norepinephrine while
activating cAMP response and  induce genetic transcription
which code various cytokines. Genetic expression changes
mediated by glucocorticoid hormone while cathecolamines may
disrupt the immune system regulation.20
Figure 1.The figures show variability within group of study and
between group differences: macrophages phagocytosis index (A),
macrophages NO (B) and bacterial count in log cfu/gram (C).
Lymphocyte, monocyte or macrophage and granulocytes
possess receptors for neuroendocrine products from HPA axis
and SAM, like cortisol and cathecolamines which cause
changes in cellular communication, proliferation, cytokine
secretion, antibody production and cytolytic.21 Marshall et al
found that  invitro cathecolamine administration in peripheral
blood leukocytes (PBLs) may suppress IL-2 synthesis and
increases IL-10 production. This can cause shifting of T
helper CD4+phenotype from TH1 which has functions in
cellular immunity to TH2 which plays roles in antibody
production. Cytokine TH1 synthesis decrease  interferon-
(IFN- ) while   cytokine TH2 increase  IL-10 production.
Then it is believed that stress can diminish TH1 cytokine
which disrupts the cellular imnunity.22
Monoaminergic neurons in the pons, in normal condition
provides descending inhibition to the spinal cord as
nociceptive transmission “brake”. Ascending fibers through
spinothalamic tract springs out neurons to thalamus and
periaqueductal grey matter (PAG) which possesses direct or
indirect interaction with the lymbic system and
monoaminergic nucleus. Periaqueductal grey matter (PAG)  is
an important nociceptive regulator site, where cognitive and
emotional sensation from thalamus or anterior cortex area
meets vegetative aspect from hypothalamus.23-24 Although
PAG is not connected directly to spinal cord dorsal horn
through pons and medulla,23 it is PAG which starts
descending and ascending inhibition to decrease pain.
Concurrent with the statement, PAG stimulation shows deep
antinociceptive,25-26where electrolytic lesion decrease
morphine analgesic effect.27 This data shows that this area of
the brain is the main site for  opioids to produce analgetic
effect. Dorsal raphe nuclei (DRN) anatomically or
functionally connected to PAG. PAG regulates pain
information by activating DRN in rostral ventromedial
medulla which causes 5-HT release in dorsal horn to inhibit
the sensory stimulus.28 Monoaminergic neurons project to
various brain regions and involved in pain, mood, affective
dimension of pain regulation. Ascending projection
dysfunction from Dorsal raphe nuclei (DRN), Locus
coeruleus (LC) and Ventral tegmental area (VTA) play role in
classic depression symptoms. Cortical structure activation in
human can be shown in imaging study of pain response.29-33
Fluoxetine is a Serotonin selective reuptake inhibitors
(SSRIs) which inhbits 5-HT transporter (5-HTTT). So that it
increases monoamine extracellular concentration in synaps
and prolongs work duration in post-synaptic level. In the
presynaptic level, 5-HTT inhibits in serotoninergic cell body
leading to accumulation of 5-HT around 5-HT1A
autoreceptors or α2 in dorsal raphe (DR). This will  increase
DR 5-HT neuron dose dependent induced   resulted from
neuronal elements activation produced by negative
feedback.34 In the nerve terminals, 5-HT accumulation also
appears  to be  the  aswer to 5-HTTT inactivation by SSRIs
and monoamine extracellular level increase observed by
microdialysis of various brain regions.35 Fluoxetine also
increases endogenic opioid receptors density besides its clear
effect in mice brain serotonin.36
This study proves that early fluoxetine administration in
chronic pain condition (PFA) increases macrophage
phagocytic index 2,24±1,013 and macrophage NO 0,24±0,239
pg/mL. The increase of macrophage phagocytic index
4,32±1,459 and macrophage NO 0,54±0,294 pg/mL also
found in late fluoxetine administration (PFL). Increasing
macrophages response such as macrophage phagocytic index
and macrophage NO of PFA is comparable to control (C)
(p=1,000; p=1,000). Onthe other hand  the increasing
macrophages response inPFL is significantlyhigher compared
to chronic pain group (P) (p=0,002; p=0,017 )(Fig 1). This
fact shows that fluoxetine may influence macrophage
response. This result is supported by previous study that
Serotonin transporter (SERT) inactivation related to 5-HT
Internat. J. Sci. Eng., Vol. 9(1)2015:27-33, July 2015, Dwi Pudjonarko et al.
30© IJSE – ISSN: 2086-5023, 15th July, 2015, All rights reserved
extracellular level increase is a relevant strategy to alleviate
pain, this is supported by observation that analgesics induced
by morphine was strengthened in deficient 5-HTT mice.37
Although spontaneous pain sensitivity in this mutant mice
was not change compared to non-mutants,37 proof from
various sources show 5-HTT blockade by SSRIs alleviate
acute pain in hot plate and tail flick test in rats38-49 and mice.50-
54 Fluoxetine administration in chronic pain will instantly
increase 5-HT level needed in pain modulation in
Periaqueductal gray (PAG) as the meeting point of cognitive
sensation and emotion from thalamus or anterior cortex area
with vegetative aspect  from hypothalamus.24,25 Elimination of
negative glucocorticoid feedback in HPA axis causes positive
regulationto axis and downeregulationof glucocorticoid
receptors in brain and peripher caused by chronic pain
immediately repaired by late fluoxetine administration so that
macrophage function response increases significantly
compared to P group. This data shows that fluoxetine can
function as macrophage activity  stimulator if administered
slowly in chronic pain. Early fluoxetine administration in
chronic pain will immediately increase 5-HT so that it
prevents the elimination of negative glucocorticoid feedback
in HPA axis. Immune response in early fluoxetine resembles
immune response in normal condition because the body
immunity has not been disrupted as late fluoxetine
administration, so that the early fluoxetine functions as an
macrophage activity  regulator.
Figure 2. The figure shows positive correlation between
macrophages phagocytosis index and macrophages NO (A), negative
correlation between macrophages phagocytosis index and bacterial
count (log cfu/gram) (B) also macrophages NO and bacterial count
(log cfu/gram) (C).
Ability to eliminate bacteria is an interaction of various
body immunity in countering foreign pathogen. Listeria
monocytogenesis  was used in this study with liver and spleen
as the main infection site. Figure 3 shows collonies of Listeria
monocytogenes in blood-tellurite agar).Listeria
monocytogenes bacterial count is highest in the chronic pain
group (P) i.e 2,30±0,849 log cfu/ gram, on the contrary  the
lowest bacterial count was  found in the control group (C)
1,15±0,223 log cfu/ gram with significant difference
(p=0,007). Highest bacterial count in chronic pain shows
body immune system failure to eliminate bacterias.
Fluoxetine administration in chronic pain is proven both in
group receiving early fluoxetine (PFE) and  in late fluoxetine
(PFL) compared to chronic pain (P) group. Bacterial count  in
PFE and PFL are equal to control group (C) (p=0,093 and
p=0,220)(Fig 1). This study shows that both early and  late
fluoxetine administration in chronic pain may suppress
bacterial growth to the same level as mice with no chronic
pain. This proves that Fluoxetine administration influences
mice liver bacterial count decrease in chronic pain.
Figure 3. The figure shows collonies of Listeria monocytogenes in
blood-tellurite agar.
This study shows strong positive correlation between
macrophage phagocytic index with macrophage NO level
(r=0,515; p=0,005)(Fig 2), so it is well demonstrated that
besides functioning as antidepressant and anti-nociceptive,
fluoxetine also functions as macrophage activity  modulator
in chronic pain. Macrophage function has weak negative
correlation towards liver bacterial count both for macrophage
phagocytic index (r=-0,051; p=0,798)and macrophage NO
(r=-0,071; p=0,719)(Fig 2).
Previous studies showed that Listeria
monocytogenes main site of infection is in liver and spleen.
Bacterias found in the Antigen presenting cell (APC) cytosol
and hepatocyte. Listeria monocytogenes may spread from cell
to cell without leaving the intracellular compartment, this has
been the reason behind the need of T CD8+cells to cleanse the
bacteria and improve immunologic protection.55Early
bacterial growth in first day after infection was controlled by
natural immunity cell like neutrophils, Natural killer (NK)
cells and macrophages.56-58 One of the main target of Listeria
monocytogenes infection is monocytes which is an integral
part of natural immunity also adaptive immunity effector. T
cell interaction with monocytes is very important for host
survival against Listeria monocytogenes. T cells don’t
eliminate Listeria monocytogenes, instead only lysis infected
cells59 in the process of releasing the living bacteria.60 The
main function of T cells in the defense mechanism againts
Listeria monocytogenes is to help increasing monocyte
response. Previous studies in the late decades had clearly
identified susceptibility to primary infection of Listeria
monocytogeneshad a correlation with monocyte function
differentiation based on age.61,62
Negative correlation of macrophage phagocytic index to
bacterial count in this study is relevant to previous studies
which indicated not to give up to Listeria monocytogenes
infection, as phagocyte cells like monocytes/ macrophages
has to trap and eliminate captured bacterias immediately.60-
61,63-64 Response arises since Listeria monocytogenes was in
contact with monocytes in a process to eliminate the
bacteria.65Listeria monocytogenes enter monocytes/
macrophages through phagocytosis process. The process has
been started after Listeria  bound to complement alongside
internalin listeria protein B and lipoteichoic lipid, functioning
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found lower in the group receiving fluoxetine ( PFE and PFL) compared to chronic pain
group (P).
Figure 2. The figure shows positive correlation between macrophages phagocytosis
index and Lymphocytes gamma-interferon (A); Lymphocytes gamma-interferon and
macrophages NO (B) also macrophages phagocytosis index and macrophages NO.
This study proves that fluoxetine administration in chronic pain condition will increase
the macrophage phagocytic index such has been showed by the highest index found in mice
group receiving late fluoxetine (PFL) and significant difference compared to mice in chronic
pain group (P) (p=0,002). This study also shows th t arly fluoxeti e administration in
chronic pain (PFE) will lead to higher phagocytic index compared to chronic pain (P) and this
increase has response comparable to control (C) (p=1,000). This fact shows that fluoxetine
may influence phagocytic index through HPA-Axis with possibility of modifying cortisol
level influential to macrophage phagocytic ability.
found lower in the group receiving fluoxetine ( PFE and PFL) compared to chronic pain
group (P).
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Figure 3. The figure shows negative correlation between bacterial count (log cfu/gram)
and macrophages phagocytosis index (A), Lymphocytes gamma-interferon (B); also
macrophages NO (C).
This study finds interferon-γ lmphocyte lowest in chronic pain mice group (P) i.e
14,60 (SD=1,098) pg/ml, while the highest is the late fluoxetine group (PFL) i.e 18,33
(SD=2,957)p /ml. This study also shows fluoxetine administration at e rly phase f chronic
pain (PFE) will cause interferon-γ lymphocyte higher than chronic pain (P) and this increase
has response comparable to control group (C) (p=1,000). This result shows that chronic pain
may suppress interferon-γ lymphocyte production needed for TH1 response and fluoxtine
administration may increase interferon-γ lymphocyte in chronic pain. TH1 differentiation
happens as a response to bacteria infecting or activating macrophage which activates NK
cells. CD4+ T cells differentiation activated to TH1 effector innduced by intracellular
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as ligand for complement receptors recognize by scavenger
receptor in phagocytosis process.66The ability of macrophage
phagocytosis  called latex phagocytoted by macrophages
showed in Figure 4.
Figure 4. The figures show latex phagocytoted by macrophages NO.
Negative correlation between macrophage NO level
towards bacterial count in this study is supported by previous
study showing that after tightly bond to scavenger receptors
or complement receptors, bacteria will be inserted into
phagosome. Phagosome will undergo serial transformation
through a series of interaction with endocytosis pathway sub
compartment which ends at phagolisosome maturity. During
the process, consumed bacterias are subject to microbisidal
effector dependent to pH including ROS and RNS (produces
NO), iron scavenger dan exporter,lactoferrin dan natural
resistance-associated macrophage protein1 (NRAMP1),
anctimicrobial peptides and proteins (such asdefensins,
cathelicidins, lisozyme, carbohydrate hydrolase, fosfolipase
and various protease dan peptidase) which perforate and
destroy the bacteria.67
Natural immune system effector has the ability to control
infection only at limited time in mice, just as mice Severe
combined immunodeficiency (SCID) upholds the infection68
but the immune system can not perform sterilization. Natural
immune sytem has to activate adaptive immunity to
completely end Listeria monocytogenes. The adaptive
immune response peak for Listeria monocytogenes in  mice is
about one week after infection. Previous studies with mice
infection model had shown that T cells response is an integral
part in Listeria monocytogenes elimination while humoral
response only plays small part.69-70 Antigen presentation
through Major histocompatibility complex (MHC) I and
MHC II pathway are mainly mediated by dendritic cells,
activating T CD8+ dan CD4+cells specific to Listeria
antigens.,T cytotoxic CD8+ cell is more important than
CD4+in controlling listeriosis,71 although it is still unclear
and  several mechanisms of protection potency related to it is
still on debate. Natural cytokine IL-12p70 is important to T
CD8+cells expansion phase,72 IL-12p70 arises to activate T
cell to be a full effector needed to control Listeria
monocytogenes infection. T CD4+cell role needs IFN-γ
production by these cells and involves macrophage feedback
activation.73 T CD4+cell presence is important to early phase
of priming T CD8+cell and for long term memory.69,74-75 T γδ
murine cell also known to play part in IFN-γ production
during infection.76
The weak correlation of macrophage phagocytic index or
macrophage NO to liver bacterial count show the complexity
of immune response against Listeria monocytogenes. Still
There are a lot of factors contributing to killing mechanism
against Listeria monocytogenes that have not been studied yet.
The weakness of this study is that there are some other
factors from the bacterias and other immunologic parameters
in the phagocytosis process particularly for Listeria
monocytogenes such as the role of neutrophil, NK  cells,
lymphocyt γ-interferon, lymphocyt proliferation index and T
CD8+.Inphagocytosis process against Listeria monocytogenes
seems that NO is not the only dominant factors, although it is
mentioned in the reference that RNI is more dominant in mice.
One of the chance of elimination can be caused by the more
influential ROS. Interaction between NO and ROS is very
complex. Sometimes both molecules inactivate each other,
but through other mechanism sometimes combine to form the
highly reactive peroxynitrite.77
Macrophage activity increase marked by high macrophage
phagocytic index and macrophage NO in chronic pain
receiving fluoxetine has been proven in this study. This
increase is strengthened by the no difference between group
receiving fluoxetine compared to control  furthermore chronic
pain group shows bacterial count significantly higher
compared to control. Fluoxetine administered early in chronic
pain shows insignificanty different macrophage activity
compared to control either in  macrophage phagocytic index
variables, or macrophage NO or bacterial count. This shows
that fluoxetine functions as an macrophage activity  regulator
which influences body cellular immunity to return the
function back to the original condition as the control group.
Fluoxetine administered slowly in chronic pain also shows
insignificant difference compared to control either in
macrophage phagoctic index or macrophage NO. However in
comparison with  chronic pain group, it is clear that
administration of fluoxetine result in significantly higher
score of macrophage phagoctic index and macrophage NO .
This shows that fluoxetine administered slowly in chronic
pain functions as an macrophage activity  stimulator which
influences body cellular immunity by increasing its function
significantly in chronic pain. Fluoxetine administration in
early chronic pain functions as an macrophage activity
regulator, while late administration functions as an
macrophage activity stimulator. Besides functioning as
antidepressant and analgetic mentioned in previous reference,
this study adds fluoxetinefunction as an macrophage activity
modulator in chronic pain.
IV.CONLUSIONS
Fluoxetine increases macrophage phagocytic index and
macrophage nitric oxide concentration in mice with chronic
pain, on the other hand fluoxetine decreases  liver bacterial
count . There is a positive correlation betweeen macrophage
phagocytic index and macrophage NO concentration, while
weak negative correlation occurs among two variables with
mice liver bacterial count in chronic pain. This study suggests
fluoxetine administration in early chronic pain may functions
as macrophage activity regulator. The study result provides an
alternative that fluoxetinein chronic pain may be administered
early or late. There are  still possibilities for thids study to be
developed further to determine other immune system role
(neutrophil, NK  cells,  lymphocyt γ-interferon , lymphocyt
proliferation index and T CD8+ cells), while ROI can be
observed to describe the killing mechanism.
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